CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Mosaic ImmunoEngineering Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.33+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.41M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Sep 30, 2025, from 13F filings
Held by institutions
0.0%
0M of 7M shares
Institutional holders
1
0 new, 0 sold out
Net institutional buying
0M
In Q3 2025
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Top institutional holders
13F holdings as of Sep 30, 2025
| Holder | Shares | % of CPMV | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| West Oak Capital, LLC | 1 | 0.00% | $0 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2022 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Robert L. Garnick Director | Jan 29, 2021 | Conversion | +356,794 | – | – | 356,794 |
| Steven W. King President and CEO, Director, 10% owner | Jan 29, 2021 | Conversion | +1,641,252 | – | – | 1,641,252 |
| Paul J. Lytle EVP, Chief Financial Officer, Director, 10% owner | Jan 29, 2021 | Conversion | +1,641,252 | – | – | 1,641,252 |
| Nicole Franziska Steinmetz Acting CSO, Director, 10% owner | Jan 29, 2021 | Conversion | +570,870 | – | – | 570,870 |
| Nicole Franziska Steinmetz Acting CSO, Director, 10% owner | Jan 29, 2021 | Conversion | +1,641,252 | – | – | 1,641,252 |
| Clifford L. Flowers CFO and Interim CEO | Apr 17, 2013 | Option exercise | +75,000 | $0.10 | $7.50K | 75,000 |
| Gloria Felcyn Director | Apr 30, 2012 | Award | +48,200 | $0.10 | $4.82K | 951,690 |
| Gloria Felcyn Director | Apr 27, 2012 | Award | +4,500 | $0.10 | $450 | 903,490 |
| Gloria Felcyn Director | Apr 26, 2012 | Award | +89,290 | $0.10 | $8.93K | 898,990 |
| Helmut Falk Jr Director | Dec 9, 2009 | Option exercise | +100,000 | $0.07 | $7.00K | 2,622,731 |
| Helmut Falk Jr Director | Oct 27, 2009 | Sale | −25,000 | $0.30 | $7.50K | 2,522,731 |
| Paul R. Bibeau VP, Business Development | Apr 15, 2009 | Buy | +100,000 | $0.10 | $10.00K | 400,000 |
| Paul R. Bibeau VP, Business Development | Jan 30, 2009 | Buy | +98,000 | $0.12 | $11.76K | 298,000 |
| Paul R. Bibeau VP, Business Development | Jan 30, 2009 | Buy | +2,000 | $0.11 | $220 | 300,000 |
| Carlton M. Johnson Director | Nov 26, 2008 | Buy | +46,800 | $0.12 | $5.62K | 431,800 |
| Carlton M. Johnson Director | Nov 26, 2008 | Buy | +30,000 | $0.11 | $3.30K | 461,800 |
| Carlton M. Johnson Director | Nov 26, 2008 | Buy | +63,200 | $0.11 | $6.95K | 525,000 |
| Carlton M. Johnson Director | Nov 25, 2008 | Buy | +10,000 | $0.11 | $1.10K | 385,000 |
| Helmut Falk Jr Director | Nov 21, 2008 | Buy | +100,000 | $0.11 | $11.00K | 200,000 |
| Frederick C. Goerner Chief Executive Officer | Nov 21, 2008 | Buy | +80,000 | $0.12 | $9.60K | 400,000 |
| Frederick C. Goerner Chief Executive Officer | Nov 21, 2008 | Buy | +20,000 | $0.11 | $2.20K | 320,000 |
| Paul R. Bibeau VP, Business Development | Nov 21, 2008 | Buy | +62,780 | $0.11 | $6.91K | 122,780 |
| Paul R. Bibeau VP, Business Development | Nov 21, 2008 | Buy | +10,000 | $0.11 | $1.10K | 60,000 |
| Paul R. Bibeau VP, Business Development | Nov 21, 2008 | Buy | +15,500 | $0.11 | $1.71K | 138,280 |
| Paul R. Bibeau VP, Business Development | Nov 21, 2008 | Buy | +61,720 | $0.12 | $7.41K | 200,000 |
| Frederick C. Goerner Chief Executive Officer | Nov 20, 2008 | Buy | +189,000 | $0.12 | $22.68K | 300,000 |
| Frederick C. Goerner Chief Executive Officer | Nov 20, 2008 | Buy | +111,000 | $0.11 | $12.21K | 111,111 |
| Harry L. Tredennick Director | Nov 20, 2008 | Buy | +115,959 | $0.11 | $12.76K | 115,959 |
| Harry L. Tredennick Director | Nov 20, 2008 | Buy | +64,041 | $0.11 | $7.04K | 180,000 |
| Carlton M. Johnson Director | Nov 20, 2008 | Buy | +100,000 | $0.11 | $11.00K | 375,000 |
| Gloria Felcyn Director | Nov 20, 2008 | Buy | +36,520 | $0.11 | $4.02K | 658,870 |
| Gloria Felcyn Director | Nov 20, 2008 | Buy | +163,480 | $0.12 | $19.62K | 822,350 |
| Gloria Felcyn Director | Nov 20, 2008 | Buy | +5,000 | $0.11 | $550 | 827,350 |
| Gloria Felcyn Director | Nov 20, 2008 | Buy | +75,000 | $0.11 | $8.25K | 622,350 |
| Helmut Falk Jr Director | Oct 21, 2008 | Option exercise | +100,000 | $0.05 | $5.00K | 2,543,231 |
| Helmut Falk Jr Director | Jun 30, 2008 | Buy | +50,000 | $0.19 | $9.50K | 2,603,231 |
| Helmut Falk Jr Director | Jun 30, 2008 | Buy | +50,000 | $0.20 | $10.00K | 2,553,231 |
| Paul R. Bibeau VP, Business Development | Apr 24, 2008 | Buy | +50,000 | $0.37 | $18.50K | 50,000 |
| Frederick C. Goerner Chief Executive Officer | Apr 15, 2008 | Buy | +190,000 | $0.33 | $62.70K | 290,000 |
| Frederick C. Goerner Chief Executive Officer | Apr 15, 2008 | Buy | +10,000 | $0.32 | $3.20K | 300,000 |
| Gloria Felcyn Director | Apr 15, 2008 | Buy | +10,000 | $0.31 | $3.10K | 499,700 |
| Gloria Felcyn Director | Apr 15, 2008 | Buy | +5,000 | $0.32 | $1.60K | 504,700 |
| Gloria Felcyn Director | Apr 15, 2008 | Buy | +25,000 | $0.32 | $8.00K | 529,700 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +5,000 | $0.39 | $1.95K | 65,000 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +7,500 | $0.39 | $2.93K | 35,000 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +10,000 | $0.39 | $3.90K | 45,000 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +5,000 | $0.38 | $1.90K | 22,500 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +7,500 | $0.38 | $2.85K | 17,500 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +10,000 | $0.38 | $3.80K | 10,000 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +2,500 | $0.39 | $975 | 100,000 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +25,000 | $0.39 | $9.75K | 97,500 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +7,500 | $0.39 | $2.93K | 72,500 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +5,000 | $0.38 | $1.90K | 27,500 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +7,500 | $0.39 | $2.93K | 60,000 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +7,500 | $0.39 | $2.93K | 52,500 |
| Gloria Felcyn Director | Sep 14, 2007 | Option exercise | +100,000 | $0.10 | $10.00K | 489,700 |
| David Pohl Director | Aug 28, 2007 | Tax withholding | −173,404 | $0.47 | $81.50K | 1,882,846 |
| David Pohl Director | Aug 28, 2007 | Option exercise | +500,000 | $0.16 | $80.00K | 2,056,250 |
| Helmut Falk Jr Director | Aug 7, 2007 | Option exercise | +25,000 | $0.07 | $1.75K | 2,503,231 |
| David Pohl Director | Aug 6, 2007 | Option exercise | +1,000,000 | $0.17 | $170.00K | 1,900,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.